Results 31 to 40 of about 844,039 (301)
Relationship between serum NDRG3 and papillary thyroid carcinoma
Frontiers in Endocrinology, 2022 BackgroundIn recent years, papillary thyroid carcinoma is considered to be one of the fastest increaseing cancer. NDRG family member 3 (NDRG3) has been proposed as a molecular marker of tumor, and is expected to be used in clinic.MethodsEnzyme-linked ...
Jiahao Wang +5 more
doaj +1 more source
The Korean Journal of Pathology, 2014 Digital papillary carcinoma (DPC) is a rare, slow growing, malignant tumor with eccrine differentiation that occurs predominantly in digits. This tumor was originally classified as a benign neoplasm; aggressive digital papillary adenoma (ADPA) was first described by Helwig in 1979 [1]. In 1987, Kao et al.
Lim, Sharon, Cho, Inju, Lee, Mi Ja
openaire +2 more sources
Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
Cancer Cell International, 2020 Background Papillary carcinoma is an uncommon type of breast cancer. Additionally, patients with huge breast papillary carcinoma are extremely rare in clinical practice. To improve therapeutic effect on such patients, it is urgent to explore biologically
Xuelu Li +6 more
doaj +1 more source
Intracystic Papillary Carcinoma of Breast: Report of Two Cases [PDF]
Journal of Clinical and Diagnostic Research, 2021 Malignancy of breast presenting as cystic lesion is a complex entity to the surgeon and pathologist especially when there is a large cyst at the previous mastectomy site. The incidence of papillary carcinoma is 0.5% of all the invasive carcinomas of the
ABISHEK H KARTHIK, Lisha Suraj
doaj +1 more source
International Journal of Surgery Case Reports, 2016 Thyroglosal duct cyst is a common anomaly with an incidence of 7% in adults, the rate of carcinoma in TGDC is 0.7-1.6%, and are extremely rare those originated in the hyoid bone.A 60 years old male patient, had a hard mass in the anterior neck. CT revealed a hyoid tumor.
López-Gómez, Javier +2 more
openaire +2 more sources
Liposomal siRNA Delivery in Papillary Thyroid Carcinoma Cells
, 2022 The discovery of RNA interference (RNAi) has opened a new strategy in cancer therapy, especially by silencing target genes. Pharmacologically it can be achieved by introducing of small (19–21 base pairs) dsRNA molecules known as small interfering RNA ...
Islam, F, Lam, AK, Zhou, Y
core +1 more source
“The potential role of CXCR4 and SDF-1 as indicators of tumor aggressiviness in patients with conventional papillary thyroid carcinoma” [PDF]
, 2008 Background: Functional chemokine receptors are expressed in many malignant tumors, including papillary thyroid carcinoma (PTC). These receptors promote tumor growth and metastasis in response to endogenous chemokines.
Pagano, Loredana
core +1 more source
Endocrinology Research and Practice, 2022 Objective: We aimed to evaluate the frequency and clinicopathological features of papillary thyroid carcinomas synchronized with parathyroid adenoma and to compare the “parathyroid adenoma with papillary thyroid carcinoma” and “parathyroid adenoma ...
Hale Demir +4 more
doaj
Case Reports in Oncology, 2020 Herein, we report a case of an occult thyroid cancer that was not detected as a primary tumor on preoperative ultrasonography or postoperative pathological examination, although a diagnosis of papillary thyroid carcinoma metastasis was made owing to the ...
Gai Yamashita +10 more
doaj +1 more source
Case Reports in Medicine, 2010 Warthin tumor-like papillary thyroid carcinoma is an uncommon variant of papillary thyroid carcinoma. We report a rare case of Warthin tumor-like variant of papillary thyroid carcinoma with a dedifferentiated component consisting of a solid tumor area ...
Paolo Amico +6 more
doaj +1 more source